IU organ researcher lands $9M grant to study animal transplants
The money is designed to further the work of Dr. Burcin Ekser and his team, who are working to print three-dimensional pig liver tissue from genetically engineered pig liver cells.
Medical Research
Articles
Crawfordsville startup CorVus fattens pigs for science
The newly built farm uses a high-fat, high-cholesterol diet to give animals heart disease and diabetes to help medical researchers find treatments.
Lilly signs licensing deal with biotech startup for diabetes drug
Under the agreement, Lilly will pay Sigilon Therapeutics up to $410 million if the technology hits certain milestones.
IU Med School raises $135M in NIH funding for 2017, setting record
The funds includes $7.6 million to study early-onset Alzheimer’s disease, $5.2 million to fund a clinical and translational sciences institute, and $4.8 million to fund epidemiologic databases to evaluate AIDS care in Africa.
Assembly Biosciences’ market value surges to nearly $1B, despite red ink
The 5-year-old Carmel biotech has won plenty of attention from Wall Street and has secured more than $100 million through licensing deals and a stock offering to help fund expensive clinical trials.
Is marijuana debate at a tipping point?
A fight over whether Indiana should legalize medical marijuana seems all but inevitable now.
IU med school wins $7.6M grant to study Alzheimer’s disease
The study will focus on early-onset Alzheimer’s disease, which are about 5 percent of patients.
Wanted: 1 million people to study genes, habits, health
In a quest to end cookie-cutter health care, U.S. researchers are getting ready to recruit more than 1 million people for an unprecedented study to learn how our genes, environments and lifestyles interact—and to finally customize ways to prevent and treat disease. Why does one sibling get sick but not another? Why does a drug […]
IU, Purdue get $2.55M to study breast cancer
Researchers at Indiana University and Purdue University have received $2.55 million from Susan G. Komen to study possible new treatments.
FDA issues warning to local doctor for breaking protocol on drug trial
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Dying patients have Pence’s backing on ‘right to try’ policy
Vice President Mike Pence may have just picked another fight with pharmaceutical companies—one that doesn’t involve drug prices.
Lawmakers hear bill to establish ‘hemp oil registry’ for seizure patients
One of the bill’s author said it is designed to help parents who are “up against a wall,” and he stressed that it should not be confused as a first step to medical marijuana legalization in the state.
Carmel biotech firm scores major deal with pharmaceutical giant
A small Carmel-based biotech firm has signed a deal with international drug company Allergan Plc that is worth at least $50 million and could grow to more than $2 billion under the best-case scenario.
Purdue startup focuses on prostate cancer therapy
Research developed at Purdue University and licensed by a biomedical startup could give patients with late-stage prostate cancer an alternative to hormone therapies that can develop resistance after prolonged use.
IU, Jackson Lab getting $25M to study Alzheimer’s Disease therapies
The National Institute on Aging is awarding $25 million to the Alzheimer's Disease Precision Models Center, a joint project of the Indiana University School of Medicine in Indianapolis and The Jackson Laboratory in Bar Harbor.
IU School of Medicine gets $2M gift to fund new faculty member
The Indiana University School of Medicine got the donation from the children of Indianapolis real estate developer Sidney Eskenazi. The endowed fund will be used to recruit a cancer researcher to Simon Cancer Center.
More buildings set to fall on IUPUI campus
The planned demolitions of the old IUPUI Psychiatric Research Building and the Wishard Helipad site are the next projects sparked by the land swap between IUPUI and Eskenazi Health’s parent.
IU to hire 40 faculty, spend up to $120M on new initiative
The money will be awarded from IU’s Grand Challenges Program, a new push that is designed to tackle “major and large-scale problems facing humanity” that can only be addressed by multidisciplinary research teams.
Biotech firm lands funding for cancer targeting
Animated Dynamics Inc. has raised $1.7 million in early funding to help it get its technology to market.
Transplant surgeon blasts IU Health after exit
Dr. Joseph Tector, who built IU Health’s transplant program into one of the nation’s largest before announcing his departure Friday, is seeking back wages and penalties worth $4.7 million from the hospital system.